IndraLab

Statements

Emedastine inhibits ITCH. 1 / 1

| 1

reach

"The present study showed that emedastine difumarate inhibits itch associated responses at relatively low peroral doses (0.03-0.3 mg/kg), which are comparable to clinical doses (Furue and Yamashita, 19[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

11011046

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Emedastine inhibits ITCH. 1 / 1

INDRA sources:

Databases

Reading